Brassinosteroid-independent function of BRI1/CLV1 chimeric receptors

Area of Science:

• Plant molecular biology
• Receptor-like kinase signaling
• Arabidopsis thaliana research

Background:

• Leucine-rich repeat receptor-like kinases (LRR-RLKs) are crucial for plant development and defense.
• CLAVATA1 (CLV1) and BRASSINOSTEROID INSENSITIVE 1 (BRI1) are key LRR-RLKs.

Purpose of the Study:

• To investigate the functional mechanisms of LRR-RLKs using chimeric receptors.
• To determine the roles of specific domains in CLV1 and BRI1 function.

Main Methods:

• Constructed chimeric receptors combining domains from CLV1 and BRI1.
• Assessed the ability of chimeric receptors to rescue CLV1 loss-of-function mutations in vivo.
• Introduced loss-of-function and gain-of-function mutations into BRI1 leucine-rich repeats (LRRs).

Main Results:

• Chimeric receptors with a BRI1 extracellular domain and CLV1 kinase domain partially rescued CLV1 function.
• Mutations in the BRI1 LRR domain modulated the extent of rescue.
• Chimeric receptor function was independent of brassinosteroid (BR) treatment.

Conclusions:

• The BRI1 LRR domain likely mediates homodimerization, influencing chimeric receptor function.
• Ligand binding is not essential for the observed chimeric receptor activity.
• LRR domain mutations affect homodimerization efficiency independently of ligand binding.